Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Jubilant Biosys Selects CDD Vault to Communicate Research Data With Customers for Next Five Years
  • USA - English
  • USA - Français
  • USA - Deutsch

Jubilant Biosys

News provided by

Jubilant Biosys

08 May, 2019, 16:46 IST

Share this article

Share toX

Share this article

Share toX

CDD Vault to support Jubilant networked research to advance the collaborative experience with their customers

NOIDA, India and BURLINGAME, California, May 8, 2019 /PRNewswire/ -- Jubilant Biosys and Collaborative Drug Discovery (CDD) announced today, following an exhaustive evaluation, Jubilant has chosen CDD Vault as their discovery research informatics platform for the next 5 years. Jubilant will be using CDD Vault as their informatics platform to facilitate and boost transparent distribution of research data and information. CDD Vault manages biological assay data, involved chemical structures, reactions and compound properties in a cohesive environment.

Continue Reading
Jubilant Biosys Selects CDD Vault to Communicate Research Data with Customers for Next Five Years
Jubilant Biosys Selects CDD Vault to Communicate Research Data with Customers for Next Five Years

"CDD Vault will be used across Jubilant research sites; to keep experimental information centralized, both structured and unstructured, to share with clients," said Marcel Velterop, President of Drug Discovery Services & CDMO at Jubilant Biosys Limited. "Scientists will be able to explore their chemistry and biology data in real-time, enabling rapid decision-making of discovery programs with CDD Vault."

"Jubilant is a leading collaborator for pharmaceutical and biotechnology companies worldwide and we are delighted to assist them in sharing their high quality preclinical R&D services with the life science industry," said Dr. Mariana Vaschetto, General Manager, CDD Global Business. "CDD Vault has been designed for collaborative research within or between organizations in a secure and easy to use way. We are looking forward to this long term relationship with Jubilant and helping them ensure the success of their customers' research."

About Collaborative Drug Discovery

CDD's (www.collaborativedrug.com) flagship product, 'CDD Vault®', is used to manage chemical registration, structure activity relationships (SAR) and securely scale collaborations. CDD Vault®, a hosted database solution for secure management and sharing of biological and chemical data. It lets you intuitively organize chemical structures and biological study data and collaborate with internal or external partners through an easy-to-use web interface. Available modules include Activity & Registration, Visualization, Inventory and ELN.

About Jubilant Biosys Limited

Jubilant Biosys, a subsidiary of Jubilant Life Sciences Ltd., is an integrated global pharmaceutical and life sciences company, has presence in Bengaluru and Noida in India. Jubilant Biosys has demonstrated expertise across multiple therapeutic areas including but not limited to Oncology, Metabolic Disorders, Pain & Inflammation and CNS. Business models include both functional and integrated discovery services up to IND including GLP as well as Phase 1/2 GMP supplies, as core components which are available for collaborative research.

Image: https://mma.prnewswire.com/media/883930/Jubilant_Biosys_CDD_Vault.jpg  

Logo: https://mma.prnewswire.com/media/821405/Jubilant_Biosys_Logo.jpg  

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.